Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 353 participants.
Also called NCT01451398
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 353 participants
- Sponsor
- Registry
-
NCT01451398
-
- Other papers using this trial's data
- Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Brazil, Russia, Ukraine
- Registry status
- Completed
Technical summary
Registry record NCT01451398. Randomized; double masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2013-06 (actual). Results posted on 2014-10-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Technosphere® Insulin
- Intervention (Drug)
- Technosphere Powder
- Lead sponsor
- Mannkind Corporation
Record details
- Record id
cardio:ct-nct01451398- Content hash
4c105e0fa4bc24b22e68d2e7c69a1004171851909c88d9d18bf29e4cd45ff9ea